Akshay Bagai

MD, FRCPC, MHS

Investigator

Biography

Please note Dr. Bagai will not be taking any summer students.

Dr. Akshay Bagai is a practicing interventional cardiologist at St. Michael’s Hospital and an Assistant Professor in the Department of Medicine at the University of Toronto. Dr. Bagai received his MD and trained in Internal Medicine and Cardiology at the University of Toronto. He completed his training in Interventional Cardiology at St. Michael’s Hospital.  He obtained a Masters degree in Health Sciences from the Clinical Research Training Program at Duke University, USA. He returned to Toronto and joined the Division of Cardiology at St. Michael’s Hospital in August 2014. His clinical and research interests are closely aligned and include systems of care for acute coronary syndrome and out-of hospital cardiac arrest, adjunctive therapy in coronary syndromes and percutaneous coronary intervention, and revascularization strategies in acute and stable coronary disease.

Recent Publications

  1. Selvakumar, D, Graham, JJ, Buller, CE, Bagai, A. Cage-Free Chronic Occlusion PCI: Multivessel Total and Subtotal Occlusion Treatment With Drug Coated Balloon Angioplasty. Catheter Cardiovasc Interv. 2024; :. doi: 10.1002/ccd.31320. PubMed PMID:39625071 .
  2. Carrier, FM, Cooper, HA, Portela, GT, Bertolet, M, Lemesle, G, Prochaska, M et al.. Anemia Acuity Effect on Transfusion Strategies in Acute Myocardial Infarction: A Secondary Analysis of the MINT Trial. JAMA Netw Open. 2024;7 (11):e2442361. doi: 10.1001/jamanetworkopen.2024.42361. PubMed PMID:39485351 PubMed Central PMC11530937.
  3. Portela, GT, Carson, JL, Swanson, SA, Alexander, JH, Hébert, PC, Goodman, SG et al.. Effect of Four Hemoglobin Transfusion Threshold Strategies in Patients With Acute Myocardial Infarction and Anemia : A Target Trial Emulation Using MINT Trial Data. Ann Intern Med. 2024;177 (11):1489-1498. doi: 10.7326/M24-0571. PubMed PMID:39348705 .
  4. Goodman, SG, Steg, PG, Szarek, M, Bhatt, DL, Bittner, VA, Diaz, R et al.. Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation. Eur Heart J Cardiovasc Pharmacother. 2024;10 (4):342-352. doi: 10.1093/ehjcvp/pvae025. PubMed PMID:38658193 PubMed Central PMC11249957.
  5. Dehghani, P, Singh, J, Mancini, GBJ, Stanberry, L, Bergstedt, S, Madan, M et al.. Angiographic characteristics of patients with STEMI and COVID-19: Insights from NACMI registry. Am Heart J. 2024;271 :112-122. doi: 10.1016/j.ahj.2024.02.012. PubMed PMID:38395293 .
  6. Siu, V, Parfrey, S, Li, C, Graham, JJ, Wijeysundera, HC, Bagai, A et al.. First In-Human Use of a Novel Perfusion Balloon Catheter in the Management of Coronary Perforation. Can J Cardiol. 2024;40 (9):1675-1678. doi: 10.1016/j.cjca.2024.01.041. PubMed PMID:38378081 .
  7. Bainey, KR, Marquis-Gravel, G, Belley-Côté, E, Turgeon, RD, Ackman, ML, Babadagli, HE et al.. Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology 2023 Focused Update of the Guidelines for the Use of Antiplatelet Therapy. Can J Cardiol. 2024;40 (2):160-181. doi: 10.1016/j.cjca.2023.10.013. PubMed PMID:38104631 .
  8. Carson, JL, Brooks, MM, Hébert, PC, Goodman, SG, Bertolet, M, Glynn, SA et al.. Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia. N Engl J Med. 2023;389 (26):2446-2456. doi: 10.1056/NEJMoa2307983. PubMed PMID:37952133 PubMed Central PMC10837004.
  9. Parfrey, S, Siu, V, Graham, JJ, Vijayaraghavan, R, Li, C, Pang, J et al.. Evaluation and management of drug-eluting stent in-stent restenosis. Curr Opin Cardiol. 2023;38 (5):433-440. doi: 10.1097/HCO.0000000000001073. PubMed PMID:37477129 .
  10. Stone, GW, Ali, ZA, O'Brien, SM, Rhodes, G, Genereux, P, Bangalore, S et al.. Impact of Complete Revascularization in the ISCHEMIA Trial. J Am Coll Cardiol. 2023;82 (12):1175-1188. doi: 10.1016/j.jacc.2023.06.015. PubMed PMID:37462593 PubMed Central PMC10529674.
Search PubMed

Affiliations & Other Activities

  • Scientist, Heart & Stroke / Richard Lewar Centre of Excellence in Cardiovascular Research